C
ALNY icon

Covestor’s Alnylam Pharmaceuticals ALNY Stock Holding History

Covestor’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75K Buy
249
+38
+18% +$11.5K 0.04% 535
2026
Q1 		$70K Buy
211
+148
+235% +$50.4K 0.05% 481
2025
Q4 		$25K Sell
63
-209
-77% -$92.5K 0.01% 1179
2025
Q3 		$124K Sell
272
-69
-20% -$28.1K 0.07% 449
2025
Q2 		$111K Sell
341
-74
-18% -$20.5K 0.07% 485
2025
Q1 		$112K Sell
415
-43
-9% -$11.1K 0.07% 405
2024
Q4 		$108K Buy
458
+1
+0.2% +$263 0.07% 480
2024
Q3 		$126K Sell
457
-319
-41% -$83.1K 0.08% 390
2024
Q2 		$189K Buy
776
+44
+6% +$6.95K 0.12% 175
2024
Q1 		$110K Buy
732
+375
+105% +$62.6K 0.07% 475
2023
Q4 		$68K Buy
357
+293
+458% +$49.9K 0.05% 707
2023
Q3 		$11K Sell
64
-3
-4% -$572 0.01% 1356
2023
Q2 		$13K Buy
67
+1
+2% +$198 0.01% 1312
2023
Q1 		$13K Sell
66
-15
-19% -$3.15K 0.01% 1173
2022
Q4 		$19K Sell
81
-314
-79% -$67K 0.02% 1042
2022
Q3 		$79K Buy
395
+300
+316% +$57.2K 0.07% 477
2022
Q2 		$14K Buy
95
+2
+2% +$284 0.01% 1076
2022
Q1 		$15K Buy
93
+37
+66% +$5.64K 0.01% 1144
2021
Q4 		$10K Buy
+56
New +$10.4K 0.01% 1010

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's ALNY Position: Q2 2026 in Review

Covestor increased its Alnylam Pharmaceuticals (ALNY) stake by 18% in Q2 2026, buying an estimated $11.5K and bringing the position to 249 shares worth $75K. The position accounts for 0.04% of the portfolio, ranked #535.

Covestor first reported a position in ALNY in Q4 2021 and has held it in 19 quarters since. The position peaked at $189K in Q2 2024. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Covestor held 249 shares of Alnylam Pharmaceuticals worth $75K as of Q2 2026.
  • Covestor bought 38 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
  • Alnylam Pharmaceuticals made up 0.04% of Covestor's portfolio in Q2 2026, its #535 holding.
  • Covestor first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Alnylam Pharmaceuticals position peaked at $189K in Q2 2024.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.